Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yellow Fever Vaccine in HIV Infected Individuals
NCT03132311Phase 4Recruiting
- Sponsor
- Fundação Oswaldo Cruz
- Start
- May 2017
- Primary completion
- Dec 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of 17DD yellow fever vaccine in yellow fever (2 arms), sponsored by Fundação Oswaldo Cruz. Primary endpoint: Immunogenicity (Seroconversion and Neutralizing Antibodies) at 30 days. Started May 2017; status: recruiting.
02
Drugs
17DD yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on NCT03132311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03132311.